BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 17, 2005
View Archived Issues
Inverness Acquiring Ischemia In Stock Deal Worth $22.4M
Read More
Cambria Plans Parkinson's, ALS Research With Three NIH Grants
Read More
Other News To Note
Read More
FibroGen Adds Institutions In $100M Round To Boost HIF Work
Selling only about 15 percent to existing investors, privately held FibroGen Inc. placed about $100 million in convertible preferred stock to advance its pipeline in a variety of programs and start more. (BioWorld Today)
Read More
Pfizer Defends Celebrex As FDA Meets On Safety Of COX-2 Class
Read More